{"count": 5, "results": [{"_id": "36889761", "pmid": 36889761, "title": "COVID-19 and Early Post-Primary TB: Commonalities of Pathobiology in Pneumonitis and Therapies.", "journal": "Ann Clin Lab Sci", "authors": ["Brown RE", "Hunter RL"], "date": "2023-01-01T00:00:00Z", "meta_date_publication": "2023 Jan", "meta_volume": "53", "meta_issue": "1", "meta_pages": "153-158", "score": 50256.105, "text_hl": "This is supported by published studies that @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ and @CHEMICAL_Cholecalciferol @CHEMICAL_MESH:D002762 @@@vitamin D3@@@ could reduce the severity of both @DISEASE_COVID_19 @DISEASE_MESH:D000086382 @@@COVID-19@@@ and early @<m>DISEASE_Tuberculosis_Meningeal</m> @DISEASE_MESH:D014390 @@@post-primary TB@@@ infections.", "citations": {"NLM": "Brown RE, Hunter RL. COVID-19 and Early Post-Primary TB: Commonalities of Pathobiology in Pneumonitis and Therapies. Ann Clin Lab Sci. 2023 Jan;53(1):153-158. PMID: 36889761", "BibTeX": "@article{36889761, title={COVID-19 and Early Post-Primary TB: Commonalities of Pathobiology in Pneumonitis and Therapies.}, author={Brown RE and Hunter RL}, journal={Ann Clin Lab Sci}, volume={53}, number={1}, pages={153-158}}"}}, {"_id": "40437360", "pmid": 40437360, "title": "DRTB-HDT: a randomized controlled trial of two adjunctive host-directed therapies in rifampin-resistant tuberculosis.", "journal": "BMC Infect Dis", "authors": ["Tukvadze N", "Mashatole S", "Jacobs A", "Ngwanto T", "Heinrich N", "Van Rie A", "Crudu V", "Tudor E", "Goginashvili L", "Ibraim E", "Khosa C", "Howell P", "Rajaram S", "Naidoo K", "Niemann S", "Reither K", "Wallis RS"], "date": "2025-05-28T00:00:00Z", "doi": "10.1186/s12879-025-11072-5", "meta_date_publication": "2025 May 28", "meta_volume": "25", "meta_issue": "1", "meta_pages": "768", "score": 50240.863, "text_hl": "BACKGROUND: @DISEASE_Tuberculosis @DISEASE_MESH:D014376 @@@Tuberculosis@@@ (@<m>DISEASE_Tuberculosis_Meningeal</m> @DISEASE_MESH:D014390 @@@TB@@@) is a leading cause of morbidity and mortality worldwide. ", "citations": {"NLM": "Tukvadze N, Mashatole S, Jacobs A, Ngwanto T, Heinrich N, Van Rie A, Crudu V, Tudor E, Goginashvili L, Ibraim E, Khosa C, Howell P, Rajaram S, Naidoo K, Niemann S, Reither K, Wallis RS. DRTB-HDT: a randomized controlled trial of two adjunctive host-directed therapies in rifampin-resistant tuberculosis. BMC Infect Dis. 2025 May 28;25(1):768. PMID: 40437360", "BibTeX": "@article{40437360, title={DRTB-HDT: a randomized controlled trial of two adjunctive host-directed therapies in rifampin-resistant tuberculosis.}, author={Tukvadze N and Mashatole S and Jacobs A and Ngwanto T and Heinrich N and Van Rie A and Crudu V and Tudor E and Goginashvili L and Ibraim E and Khosa C and Howell P and Rajaram S and Naidoo K and Niemann S and Reither K and Wallis RS}, journal={BMC Infect Dis}, volume={25}, number={1}, pages={768}}"}}, {"_id": "37309381", "pmid": 37309381, "pmcid": "PMC10257915", "title": "Metformin Increases Cell Viability and Regulates Pro-Inflammatory Response to Mtb", "journal": "Infect Drug Resist", "authors": ["Naicker N", "Rodel H", "Perumal R", "Ganga Y", "Bernstein M", "Benede N", "Abdool Karim S", "Padayacthi N", "Sigal A", "Naidoo K"], "date": "2023-06-07T00:00:00Z", "doi": "10.2147/IDR.S401403", "meta_date_publication": "2023", "meta_volume": "16", "meta_issue": "", "meta_pages": "3629-3638", "score": 50237.867, "text_hl": "@<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@Metformin@@@ Increases Cell Viability and Regulates Pro-Inflammatory Response to Mtb", "citations": {"NLM": "Naicker N, Rodel H, Perumal R, Ganga Y, Bernstein M, Benede N, Abdool Karim S, Padayacthi N, Sigal A, Naidoo K. Metformin Increases Cell Viability and Regulates Pro-Inflammatory Response to Mtb Infect Drug Resist. 2023;16():3629-3638. PMID: 37309381", "BibTeX": "@article{37309381, title={Metformin Increases Cell Viability and Regulates Pro-Inflammatory Response to Mtb}, author={Naicker N and Rodel H and Perumal R and Ganga Y and Bernstein M and Benede N and Abdool Karim S and Padayacthi N and Sigal A and Naidoo K}, journal={Infect Drug Resist}, volume={16}, pages={3629-3638}}"}}, {"_id": "29253553", "pmid": 29253553, "title": "The Risk of TB in Patients With Type 2 Diabetes Initiating Metformin vs Sulfonylurea Treatment.", "journal": "Chest", "authors": ["Pan SW", "Yen YF", "Kou YR", "Chuang PH", "Su VY", "Feng JY", "Chan YJ", "Su WJ"], "date": "2018-06-01T00:00:00Z", "doi": "10.1016/j.chest.2017.11.040", "meta_date_publication": "2018 Jun", "meta_volume": "153", "meta_issue": "6", "meta_pages": "1347-1357", "score": 50059.152, "text_hl": "The Risk of @<m>DISEASE_Tuberculosis_Meningeal</m> @DISEASE_MESH:D014390 @@@TB@@@ in @SPECIES_9606 @@@Patients@@@ With @DISEASE_Diabetes_Mellitus_Type_2 @DISEASE_MESH:D003924 @@@Type 2 Diabetes@@@ Initiating @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@Metformin@@@ vs @CHEMICAL_Sulfonylurea_Compounds @CHEMICAL_MESH:D013453 @@@Sulfonylurea@@@ Treatment.", "citations": {"NLM": "Pan SW, Yen YF, Kou YR, Chuang PH, Su VY, Feng JY, Chan YJ, Su WJ. The Risk of TB in Patients With Type 2 Diabetes Initiating Metformin vs Sulfonylurea Treatment. Chest. 2018 Jun;153(6):1347-1357. PMID: 29253553", "BibTeX": "@article{29253553, title={The Risk of TB in Patients With Type 2 Diabetes Initiating Metformin vs Sulfonylurea Treatment.}, author={Pan SW and Yen YF and Kou YR and Chuang PH and Su VY and Feng JY and Chan YJ and Su WJ}, journal={Chest}, volume={153}, number={6}, pages={1347-1357}}"}}, {"_id": "30797286", "pmid": 30797286, "title": "Metformin induced autophagy in diabetes mellitus - Tuberculosis co-infection patients: A case study.", "journal": "Indian J Tuberc", "authors": ["Novita BD", "Ali M", "Pranoto A", "Soediono EI", "Mertaniasih NM"], "date": "2019-01-01T00:00:00Z", "doi": "10.1016/j.ijtb.2018.04.003", "meta_date_publication": "2019 Jan", "meta_volume": "66", "meta_issue": "1", "meta_pages": "64-69", "score": 50058.84, "text_hl": "...@<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@Metformin@@@ (@<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@MET@@@) is a potential combination drug to elevate @<m>DISEASE_Tuberculosis_Meningeal</m> @DISEASE_MESH:D014390 @@@anti-TB@@@ efficacy. ", "citations": {"NLM": "Novita BD, Ali M, Pranoto A, Soediono EI, Mertaniasih NM. Metformin induced autophagy in diabetes mellitus - Tuberculosis co-infection patients: A case study. Indian J Tuberc. 2019 Jan;66(1):64-69. PMID: 30797286", "BibTeX": "@article{30797286, title={Metformin induced autophagy in diabetes mellitus - Tuberculosis co-infection patients: A case study.}, author={Novita BD and Ali M and Pranoto A and Soediono EI and Mertaniasih NM}, journal={Indian J Tuberc}, volume={66}, number={1}, pages={64-69}}"}}]}